Maxigen Biotech Inc
TWSE:1783

Watchlist Manager
Maxigen Biotech Inc Logo
Maxigen Biotech Inc
TWSE:1783
Watchlist
Price: 41.9 TWD 0.12%
Market Cap: 3.7B TWD
Have any thoughts about
Maxigen Biotech Inc?
Write Note

Maxigen Biotech Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Maxigen Biotech Inc
Cash from Operating Activities Peer Comparison

Comparables:
G
1707
1731
4137

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Maxigen Biotech Inc
TWSE:1783
Cash from Operating Activities
NT$173.2m
CAGR 3-Years
11%
CAGR 5-Years
19%
CAGR 10-Years
N/A
G
Grape King Bio Ltd
TWSE:1707
Cash from Operating Activities
NT$1.6B
CAGR 3-Years
-14%
CAGR 5-Years
-9%
CAGR 10-Years
4%
Maywufa Co Ltd
TWSE:1731
Cash from Operating Activities
NT$246m
CAGR 3-Years
-6%
CAGR 5-Years
7%
CAGR 10-Years
6%
Chlitina Holding Ltd
TWSE:4137
Cash from Operating Activities
NT$756.7m
CAGR 3-Years
-28%
CAGR 5-Years
-13%
CAGR 10-Years
0%

See Also

What is Maxigen Biotech Inc's Cash from Operating Activities?
Cash from Operating Activities
173.2m TWD

Based on the financial report for Jun 30, 2024, Maxigen Biotech Inc's Cash from Operating Activities amounts to 173.2m TWD.

What is Maxigen Biotech Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
19%

Over the last year, the Cash from Operating Activities growth was -31%. The average annual Cash from Operating Activities growth rates for Maxigen Biotech Inc have been 11% over the past three years , 19% over the past five years .

Back to Top